Maxitrol
RxNorm concept 134920, brand name (bn).
- RxCUI
- 134920
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/134920 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- dexamethasone / neomycin / polymyxin B Ophthalmic Ointment [Maxitrol] (SBDF, ingredient of)
- dexamethasone / neomycin / polymyxin B Ophthalmic Suspension [Maxitrol] (SBDF, ingredient of)
- dexamethasone 1 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspension [Maxitrol] (SBD, ingredient of)
- dexamethasone 0.001 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Maxitrol] (SBD, ingredient of)
- dexamethasone 1 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML [Maxitrol] (SBDC, ingredient of)
- dexamethasone 0.001 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Maxitrol] (SBDC, ingredient of)
- Maxitrol Ophthalmic Product (SBDG, ingredient of)
- dexamethasone (IN, tradename of)
- neomycin (IN, tradename of)
- polymyxin B (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 134920 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/134920 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 134920. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.